1. Home
  2. MMS vs AAPG Comparison

MMS vs AAPG Comparison

Compare MMS & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMS
  • AAPG
  • Stock Information
  • Founded
  • MMS 1975
  • AAPG 2009
  • Country
  • MMS United States
  • AAPG China
  • Employees
  • MMS N/A
  • AAPG N/A
  • Industry
  • MMS Business Services
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMS Consumer Discretionary
  • AAPG Health Care
  • Exchange
  • MMS Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • MMS 4.0B
  • AAPG 3.2B
  • IPO Year
  • MMS 1997
  • AAPG 2025
  • Fundamental
  • Price
  • MMS $71.63
  • AAPG $38.24
  • Analyst Decision
  • MMS Buy
  • AAPG Buy
  • Analyst Count
  • MMS 1
  • AAPG 1
  • Target Price
  • MMS $90.00
  • AAPG N/A
  • AVG Volume (30 Days)
  • MMS 391.7K
  • AAPG 12.4K
  • Earning Date
  • MMS 08-06-2025
  • AAPG 08-06-2025
  • Dividend Yield
  • MMS 1.65%
  • AAPG N/A
  • EPS Growth
  • MMS 31.21
  • AAPG N/A
  • EPS
  • MMS 5.00
  • AAPG N/A
  • Revenue
  • MMS $5,395,260,000.00
  • AAPG $134,352,180.00
  • Revenue This Year
  • MMS $2.13
  • AAPG N/A
  • Revenue Next Year
  • MMS $3.36
  • AAPG $389.09
  • P/E Ratio
  • MMS $14.56
  • AAPG N/A
  • Revenue Growth
  • MMS 5.29
  • AAPG 341.77
  • 52 Week Low
  • MMS $63.77
  • AAPG $16.50
  • 52 Week High
  • MMS $93.97
  • AAPG $43.58
  • Technical
  • Relative Strength Index (RSI)
  • MMS 52.49
  • AAPG N/A
  • Support Level
  • MMS $70.61
  • AAPG N/A
  • Resistance Level
  • MMS $73.79
  • AAPG N/A
  • Average True Range (ATR)
  • MMS 1.58
  • AAPG 0.00
  • MACD
  • MMS 0.24
  • AAPG 0.00
  • Stochastic Oscillator
  • MMS 69.68
  • AAPG 0.00

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: